Glossopharyngeal (vagoglossopharyngeal) neuralgia: a study of 217 cases.
In 217 cases of glossopharyngeal neuralgia seen at the Mayo Clinic between 1922 and 1977, the disease was more common in patients older than 50 years (57%), but also occurred in 43% who were between 18 and 50. Spontaneous remissions were noted by 161 patients, but 37 had no periods of pain relief. Syncope was rarely a problem. Involvement was bilateral in 12%. The combination of glossopharyngeal and trigeminal neuralgia was found in 25 patients. Positive results on the cocaine test in 112 of 125 patients aided in diagnosis. Carbamazepine is the favored medication. Early surgical experience consisted of extracranial avulsion of the glossopharyngeal nerve or intracranial section at the jugular foramen; since 1948, surgical treatment has included section of the glossopharyngeal nerve and usually the upper rootlets of the vagus nerve and additional section of the fifth cranial nerve when trigeminal neuralgia was associated. Good relief of pain was obtained surgically in 110 patients.
D000293:Adolescent; D000328:Adult; D002220:Carbamazepine / Q000627:therapeutic use; D003042:Cocaine; D003389:Cranial Nerve Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology* / Q000601:surgery; D005830:Geniculate Ganglion; D005930:Glossopharyngeal Nerve / Q000503:physiopathology* / Q000601:surgery; D006801:Humans; D008875:Middle Aged; D009068:Movement; D009437:Neuralgia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology* / Q000601:surgery; D010146:Pain / Q000188:drug therapy / Q000503:physiopathology; D010672:Phenytoin / Q000627:therapeutic use; D014277:Trigeminal Neuralgia / Q000150:complications
D002220:Carbamazepine; D010672:Phenytoin; D003042:Cocaine